Physician profile
Evan B Cohn
NPI 1164463451
$3,808.83
in general payments reported to CMS, 2019-2025
30 companies · $471 in 2025
The $471 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $153 · 2021: $147 · 2022: $351 · 2023: $1,139 · 2024: $414 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,464 · Travel and Lodging: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,464.06 |
| Travel and Lodging | $560.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $900.87 | 2019-2025 | Xpeeda Dsl Fiber, Spaceoar Vue System - 10ml, Axonics |
| Procept Biorobotics Corporation | $780.43 | 2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $236.88 | 2019-2024 | Xiaflex, Aveed |
| Axonics, INC. | $221.48 | 2023-2024 | Axonics |
| Neotract INC. | $187.09 | 2019 | |
| Endo USA, INC. | $144.05 | 2024-2025 | Xiaflex, Aveed |
| Medtronic, INC. | $143.25 | 2021-2025 | Interstim, Altaviva |
| Ferring Pharmaceuticals INC. | $105.77 | 2019 | |
| Laborie Medical Technologies Corp. | $103.50 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $102.42 | 2023-2025 | Lupron Depot |
| 180 Medical, INC. | $98.42 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $96.56 | 2023-2025 | Prolaris, Myrisk |
| Urovant Sciences INC | $77.86 | 2022 | |
| Teleflex LLC | $74.94 | 2022-2025 | Barrigel, Urolift |
| Progenics Pharmaceuticals, INC. | $69.89 | 2022-2024 | Pylarify |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $59.15 | 2025 | |
| Astellas Pharma US INC | $57.71 | 2022-2023 | Veozah |
| Convatec INC. | $56.17 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $52.64 | 2023-2024 | Gemtesa, Orgovyx |
| Pfizer INC. | $45.67 | 2021-2024 | |
| Tolmar, INC. | $40.53 | 2023-2024 | |
| Rochester Medical Corporation | $34.87 | 2021 | |
| Blue Earth Diagnostics | $28.43 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $20.90 | 2022 | |
| Coloplast Corp | $15.00 | 2020 | |
| Agiliti Surgical, INC. | $14.93 | 2020 | |
| Janssen Biotech, INC. | $14.02 | 2020 | |
| Myovant Sciences INC. | $13.12 | 2022 | |
| Clarus Therapeutics INC. | $12.28 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$657.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.